ay cause actual results, levels of activity, performance or achievements to differ materially from those expressed or implied. For information about risks and uncertainties we face and a discussion of our financial statements and footnotes, see documents we have filed with the SEC, including the Form 10-K for the year ended December 31, 2008, and all subsequent periodic filings made with the SEC. We assume no obligation and expressly disclaim any duty to update any forward-looking statement to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.
Contact:
Paula Izidoro
Investor Relations
858-410-8904
'/>"/>SOURCE Gen-Probe Incorporated Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 Related biology technology :1.
Gen-Probe to Webcast Presentation at Bank of Americas 37th Annual Investment Conference2.
Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues3.
Gen-Probe to Webcast Three Upcoming Presentations4.
Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2007 Earnings Conference Call5.
Carl Hull Named President and Chief Operating Officer of Gen-Probe6.
Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 20077.
Gen-Probe to Webcast Presentations at Lehman and Cowen Healthcare Conferences8.
Gen-Probe to Webcast Presentation at Morgan Stanley Global Healthcare Unplugged Conference9.
Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance10.
Gen-Probe to Webcast Presentation at Deutsche Bank 33rd Annual Health Care Conference11.
Lucy Shapiro, Ph.D., Elected to Gen-Probe Board of Directors